ASHLEY MILLER: Open Payments
NPI 1811918261 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 48 payments from 10 companies in 2025. Trend: 2023 $870 · 2024 $1,120 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $303 |
| Janssen Biotech, Inc. | 16 | $190 |
| Madrigal Pharmaceuticals | 7 | $173 |
| GENZYME CORPORATION | 2 | $67 |
| Medtronic, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $23 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, SKYRIZI, INTERSTIM, MAVYRET, CREON.
Industry payments across PA — which companies pay providers there.
